Publication Information

{'id': 'https://openalex.org/W2341953096', 'doi': None, 'title': 'The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis.', 'display_name': 'The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis.', 'publication_year': 2006, 'publication_date': '2006-01-07', 'ids': {'openalex': 'https://openalex.org/W2341953096', 'mag': '2341953096', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/16396697'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/16396697', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5073103658', 'display_name': 'Gal Cohen', 'orcid': 'https://orcid.org/0000-0001-7944-0532'}, 'institutions': [{'id': 'https://openalex.org/I4210132125', 'display_name': 'Hôpital Lapeyronie', 'ror': 'https://ror.org/03xzagw65', 'country_code': 'FR', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210093292', 'https://openalex.org/I4210132125']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'Cohen G', 'raw_affiliation_strings': ["Service d'Immuno-Rhumatologie, Faculté de Médecine Montpellier I, Centre Hospitalier Universitaire Lapeyronie, Montpellier, France."], 'affiliations': [{'raw_affiliation_string': "Service d'Immuno-Rhumatologie, Faculté de Médecine Montpellier I, Centre Hospitalier Universitaire Lapeyronie, Montpellier, France.", 'institution_ids': ['https://openalex.org/I4210132125']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5045283030', 'display_name': 'Natacha Courvoisier', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Courvoisier N', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5027466301', 'display_name': 'Cohen Jd', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Cohen Jd', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5060297986', 'display_name': 'S. Zaltni', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Zaltni S', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5026271933', 'display_name': 'J Sany', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Sany J', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5008811878', 'display_name': 'Bernard Combe', 'orcid': 'https://orcid.org/0000-0003-4002-1861'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Combe B', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 9.92, 'has_fulltext': False, 'cited_by_count': 86, 'citation_normalized_percentile': {'value': 0.806658, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '23', 'issue': '6', 'first_page': '795', 'last_page': '800'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10200', 'display_name': 'Rheumatoid Arthritis Research and Therapies', 'score': 0.9999, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10308', 'display_name': 'Systemic Lupus Erythematosus Research', 'score': 0.9989, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11616', 'display_name': 'Autoimmune and Inflammatory Disorders Research', 'score': 0.9966, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/discontinuation', 'display_name': 'Discontinuation', 'score': 0.82133234}, {'id': 'https://openalex.org/keywords/biosimilar', 'display_name': 'Biosimilar', 'score': 0.4195258}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.9606941}, {'id': 'https://openalex.org/C2777226972', 'wikidata': 'https://www.wikidata.org/wiki/Q415343', 'display_name': 'Etanercept', 'level': 3, 'score': 0.93208647}, {'id': 'https://openalex.org/C2777138892', 'wikidata': 'https://www.wikidata.org/wiki/Q415264', 'display_name': 'Infliximab', 'level': 3, 'score': 0.89712834}, {'id': 'https://openalex.org/C2777575956', 'wikidata': 'https://www.wikidata.org/wiki/Q187255', 'display_name': 'Rheumatoid arthritis', 'level': 2, 'score': 0.8562081}, {'id': 'https://openalex.org/C2778715236', 'wikidata': 'https://www.wikidata.org/wiki/Q55622662', 'display_name': 'Discontinuation', 'level': 2, 'score': 0.82133234}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.63789696}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.62448096}, {'id': 'https://openalex.org/C2777077863', 'wikidata': 'https://www.wikidata.org/wiki/Q170990', 'display_name': 'Arthritis', 'level': 2, 'score': 0.4440371}, {'id': 'https://openalex.org/C59491497', 'wikidata': 'https://www.wikidata.org/wiki/Q864715', 'display_name': 'Biosimilar', 'level': 2, 'score': 0.4195258}, {'id': 'https://openalex.org/C17991360', 'wikidata': 'https://www.wikidata.org/wiki/Q21173843', 'display_name': 'Tumor necrosis factor alpha', 'level': 2, 'score': 0.3666121}, {'id': 'https://openalex.org/C141071460', 'wikidata': 'https://www.wikidata.org/wiki/Q40821', 'display_name': 'Surgery', 'level': 1, 'score': 0.3605981}], 'mesh': [{'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D018501', 'descriptor_name': 'Antirheumatic Agents', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D001172', 'descriptor_name': 'Arthritis, Rheumatoid', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D007074', 'descriptor_name': 'Immunoglobulin G', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D018124', 'descriptor_name': 'Receptors, Tumor Necrosis Factor', 'qualifier_ui': 'Q000008', 'qualifier_name': 'administration & dosage', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000368', 'descriptor_name': 'Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000911', 'descriptor_name': 'Antibodies, Monoclonal', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D018501', 'descriptor_name': 'Antirheumatic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018501', 'descriptor_name': 'Antirheumatic Agents', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D001172', 'descriptor_name': 'Arthritis, Rheumatoid', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015331', 'descriptor_name': 'Cohort Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000068800', 'descriptor_name': 'Etanercept', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007074', 'descriptor_name': 'Immunoglobulin G', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007074', 'descriptor_name': 'Immunoglobulin G', 'qualifier_ui': 'Q000009', 'qualifier_name': 'adverse effects', 'is_major_topic': False}, {'descriptor_ui': 'D000069285', 'descriptor_name': 'Infliximab', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008875', 'descriptor_name': 'Middle Aged', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018124', 'descriptor_name': 'Receptors, Tumor Necrosis Factor', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012189', 'descriptor_name': 'Retrospective Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014409', 'descriptor_name': 'Tumor Necrosis Factor-alpha', 'qualifier_ui': 'Q000037', 'qualifier_name': 'antagonists & inhibitors', 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/16396697', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.67, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 18, 'referenced_works': ['https://openalex.org/W1979364075', 'https://openalex.org/W1985763670', 'https://openalex.org/W2026342001', 'https://openalex.org/W2038535814', 'https://openalex.org/W2045085974', 'https://openalex.org/W2091732273', 'https://openalex.org/W2103310388', 'https://openalex.org/W2110177517', 'https://openalex.org/W2122265491', 'https://openalex.org/W2252829258', 'https://openalex.org/W2289065863', 'https://openalex.org/W2319957449', 'https://openalex.org/W2328587823', 'https://openalex.org/W2340084730', 'https://openalex.org/W2411508702', 'https://openalex.org/W2413043776', 'https://openalex.org/W2460286564', 'https://openalex.org/W2464487575'], 'related_works': ['https://openalex.org/W2413043776', 'https://openalex.org/W2411508702', 'https://openalex.org/W2319957449', 'https://openalex.org/W2163204760', 'https://openalex.org/W2157770246', 'https://openalex.org/W2152721471', 'https://openalex.org/W2152348310', 'https://openalex.org/W2133028044', 'https://openalex.org/W2125935509', 'https://openalex.org/W2122265491', 'https://openalex.org/W2116843833', 'https://openalex.org/W2112966993', 'https://openalex.org/W2110177517', 'https://openalex.org/W2108779144', 'https://openalex.org/W2040509878', 'https://openalex.org/W2024644107', 'https://openalex.org/W2014709373', 'https://openalex.org/W2000905503', 'https://openalex.org/W1996389186', 'https://openalex.org/W1840538016'], 'abstract_inverted_index': {'To': [0], 'determine': [1], 'whether': [2], 'it': [3], 'may': [4], 'be': [5, 238], 'successful': [6], 'to': [7, 20, 63, 72, 95, 108, 185, 194, 237, 250, 252], 'try': [8, 251], 'another': [9], 'TNF-alpha': [10, 182, 198, 212, 227, 234, 254], 'antagonist': [11], '(infliximab': [12], 'or': [13, 23, 40], 'etanercept)': [14], 'when': [15], 'one': [16, 201, 243], 'has': [17], 'failed': [18], 'due': [19, 62, 184], 'non': [21], 'response': [22, 123, 165], 'the': [24, 73, 86, 89, 96, 135, 149, 164, 167, 170, 174, 179, 195, 204, 224], 'development': [25], 'of': [26, 31, 66, 75, 85, 112, 134, 148, 187, 203, 241], 'side': [27, 217], 'effects.In': [28], 'a': [29, 64, 92, 109, 129, 209, 216], 'cohort': [30], '282': [32], 'patients': [33, 45, 51, 70, 137, 151, 176, 206], 'with': [34, 38, 141, 155, 223], 'rheumatoid': [35], 'arthritis': [36], 'treated': [37, 140, 154], 'infliximab': [39, 53, 142], 'etanercept,': [41], 'we': [42], 'observed': [43], '38': [44, 87], 'who': [46, 138, 152, 177, 207], 'had': [47], 'received': [48, 52, 57], 'both': [49], 'agents.Twenty-four': [50], 'first': [54, 180, 210], 'and': [55, 71, 116, 144], '14': [56, 150], 'etanercept': [58, 156], 'first.': [59, 157, 246], 'Discontinuation': [60], 'was': [61, 91, 106, 126, 159, 244], 'lack': [65, 186], 'efficiency': [67], 'for': [68, 79, 131, 145], '29': [69, 175], 'occurence': [74], 'an': [76, 220], 'adverse': [77, 221], 'effect': [78, 218], '9': [80, 205], 'patients.': [81], 'For': [82], '25': [83], 'out': [84, 133, 147, 202], 'patients,': [88], 'switch': [90, 168, 253], 'success': [93, 130], 'according': [94], 'global': [97], "physician's": [98], 'assessment': [99], '3': [100], 'months': [101], 'after': [102, 124, 166, 214], 'switching.': [103], 'This': [104], 'result': [105], 'correlated': [107], 'significant': [110], 'decrease': [111], 'DAS': [113], '28': [114], 'measurements': [115], 'CRP': [117], 'values': [118], '(p': [119], '<': [120], '0.05).': [121], 'The': [122], 'switching': [125, 232], 'recorded': [127], 'as': [128], '18': [132], '24': [136], 'were': [139, 153], 'first,': [143], '12': [146], 'There': [158], 'no': [160], 'statistical': [161], 'difference': [162], 'concerning': [163], 'between': [169, 233], 'two': [171], 'groups.': [172], 'Among': [173], 'discontinued': [178], 'anti': [181, 197, 211, 226], 'treatment': [183, 213], 'efficiency,': [188], 'only': [189], '6': [190], 'did': [191], 'not': [192], 'respond': [193], 'second': [196, 225], 'treatment.': [199], 'Only': [200], 'stopped': [208], 'developing': [215], 'underwent': [219], 'event': [222], 'treatment.Our': [228], 'study': [229], 'suggests': [230], 'that': [231], 'antagonists': [235], 'seems': [236], 'relevant,': [239], 'regardless': [240], 'which': [242], 'used': [245], 'It': [247], 'is': [248], 'legitimate': [249], 'blockers': [255], 'before': [256], 'contemplating': [257], 'other': [258], 'therapeutic': [259], 'strategies.': [260]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2341953096', 'counts_by_year': [{'year': 2021, 'cited_by_count': 2}, {'year': 2020, 'cited_by_count': 1}, {'year': 2015, 'cited_by_count': 4}, {'year': 2014, 'cited_by_count': 4}, {'year': 2013, 'cited_by_count': 5}, {'year': 2012, 'cited_by_count': 4}], 'updated_date': '2024-12-17T23:14:21.014318', 'created_date': '2016-06-24'}